Galvanize Prospective/Retrospective Pulsed Electric Field Device Registry — PROPEL  

Soft Tissue Lesion Clinical Trial

Official title: Galvanize Prospective/Retrospective Pulsed Electric Field Device Registry

Status Terminated

Clinical Trial Summary

The goal of this observational registry is to assess the use and performance of Galvanize PEF technology in a real-world setting. The main questions it aims to answer are:

• PEF utilization and performance

• Monitor safety outcomes and inform future generation devices.

Participants will undergo the PEF procedure and be followed per institutional standard of care.

Clinical Trial Description

This is a multi-center, observational registry that follows patients for a total of 2 years from the date of the Pulsed Electric Field (PEF) procedure with the FDA cleared Galvanize Technology.

Patients will be enrolled and followed prospectively or enrolled retrospectively with prospective, longitudinal follow up.

Enrollment for this study will include up to 200 patients throughout the US who underwent or are scheduled to undergo PEF energy delivery. ;

Related Conditions & MeSH terms

• Soft Tissue Lesion

• NCT number: NCT05851430
• Study type: Observational [Patient Registry]
• Source: Galvanize Therapeutics, Inc.
• Status: Terminated
• Start date: June 1, 2023
• Completion date: August 28, 2023